• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CONSERVE A-CLASS BFH HEAD SHORT NECK 48MM; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CONSERVE A-CLASS BFH HEAD SHORT NECK 48MM; HIP COMPONENT Back to Search Results
Model Number 38AM4804
Health Effect - Clinical Codes Pain (1994); Loss of Range of Motion (2032); Metal Related Pathology (4530)
Type of Reportable Event Serious Injury
Event or Problem Description
Allegedly, patient underwent a left total hip replacement and received a mom hip system implants.Patient was revised due to pain, lack of mobility and high levels of toxic metal levels.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSERVE A-CLASS BFH HEAD SHORT NECK 48MM
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key11207262
Report Number3010536692-2021-00028
Device Sequence Number11606073
Product Code KWA
UDI-Device IdentifierM68438AM48041
UDI-PublicM68438AM48041
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K021349
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 01/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number38AM4804
Device Catalogue Number38AM4804
Device Lot Number088673567
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/12/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/12/2021
Initial Report FDA Received Date01/21/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-